2019 American Transplant Congress
Variable Outcomes of Recurrent Autoimmune Diabetes Post Pancreas Transplant Treated with Rituximab
Washington University, St. Louis, MO
*Purpose: Demonstrate the outcomes of treatment with rituximab in patients with autoimmune diabetes after pancreas transplant.*Methods: We present the treatment response to rituximab in 3…2019 American Transplant Congress
Comparison of Functional β-cell Function and Insulin Sensitivity of Functioning Pancreas Transplant According to Pre-Transplant Matsuda’s Index
*Purpose: This study was performed to verify post-transplant improvement of functioning β-cell mass and insulin sensitivity of functioning pancreas transplants according to the degree of…2019 American Transplant Congress
Should Preceding Solo-Kidney Transplantation for Patients with Type 1 Diabetes with End Stage Renal Failure Be Carried Out?
*Purpose: Patients with type 1 diabetes with end stage renal failure are indicated for SPK, but if the family requests a renal donation and living…2019 American Transplant Congress
Quality of Life After Islet/Pancreas Transplantation in Insulin Dependent Diabetic Patients: A Systematic Review of the Literature.
*Purpose: To investigate the current literature on Quality of Life after Islet and Pancreas Transplantation in Insulin Dependent Diabetic Patients with or without renal failure.*Methods:…2019 American Transplant Congress
The Need for Diabetic Medications after Pancreas Transplantation
Mount Sinai Hospital, New York, NY
*Purpose: Patients with diabetes mellitus can experience microvascular complications resulting in end organ damage ultimately necessitating pancreatic transplantation. While there is well documented improvement in…2019 American Transplant Congress
Can Cxcl8 Inhibitor (reparixin) Improve Islet Engraftment And Clinical Outcomes After Islet Allotransplantation? University Of Chicago Preliminary Results From A Phase 3 Multicenter Randomized, Double-blinded, Prospective Study.
1University of Chicago Medicine, Chicago, IL, 2Medical University of Gdansk, Gdansk, Poland
*Purpose: Reparixin is a novel CxCR1/2 chemokine receptor-blocking molecule, which has been shown improving islet engraftment in animal models. A multicenter trial was organized to…2019 American Transplant Congress
Pancreas Transplantation Outcomes – A Single Center Experience 400 Cases
*Purpose: Pancreas transplant is considered as an effective treatment strategy to restore long-term euglycemia and stabilize the multiorgan complications. By June 2019, our center performed…2019 American Transplant Congress
Pre-Operative C-Peptide Predicts Weight Gain after Pancreas Transplantation
Montefiore Medical Center, Bronx, NY
*Purpose: Transplant recipients are susceptible to metabolic syndrome as typified by hyperglycemia, central obesity and increased insulin resistance after transplant, which may precede the onset…2019 American Transplant Congress
Correlates of Significant Weight Changes Following Pancreas Alone Transplantation
University of Wisconsin, Madison, WI
*Purpose: Significant weight change is defined as unintentional weight gain of ≥ 7% of body weight or unintentional weight loss of > 5% in one…2019 American Transplant Congress
Optimizing Patient Blood Management in Simultaneous Kidney and Pancreas Transplantation
University of Wisconsin, Madison, WI
*Purpose: To identify a post-operative hematocrit (Hct) target for patients recovering from simultaneous kidney and pancreas (SPK) transplant and pancreas transplant alone (PTA) that is…
- « Previous Page
- 1
- …
- 586
- 587
- 588
- 589
- 590
- …
- 1683
- Next Page »